Hormonal manipulation after surgery for catamenial pneumothorax

Megan Garner, Eltayeb Ahmed, Eltayeb Mohamed Ahmed, Sarah Gatiss, Douglas West
Interactive cardiovascular and thoracic surgery · 2017 · vol. 26(2) , pp. 319–322 · doi:10.1093/icvts/ivx319 · PMID:29049784 · W2758488822
review OA: bronze CC0 ⤵ 10 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was whether hormonal manipulation with gonadotrophin-releasing hormone analogues reduces the risk of recurrent catamenial pneumothorax after surgery, compared with surgery alone. Altogether 819 papers were found using the reported search, of which 7 represented the best evidence to answer the clinical question. The authors, date, journal, country of publication, study type, level of evidence, patient group studied, relevant outcomes and results of these papers are tabulated. Of the 7 papers selected, 6 demonstrated a reduction in recurrence of catamenial pneumothorax with the use of gonadotrophin-releasing hormone analogues, whereas in the single paper where surgery alone was performed, no evidence of recurrence was demonstrated. We therefore conclude that, based on very small retrospective observational studies, gonadotrophin-releasing hormone analogues used as an adjunct to surgical intervention may reduce the risk of recurrent pneumothorax, when compared with either no hormonal therapy or oestrogen-progesterone therapy, but should be initiated and supervised by gynaecologists who will be familiar with the therapy and the potential side effects.

My notes (saved in your browser only)

MeSH descriptors

Hormones Pneumothorax Secondary Prevention Thoracic Surgery, Video-Assisted Adult Female Hormones Humans Pneumothorax Pneumothorax Recurrence Retrospective Studies Secondary Prevention Thoracic Surgery, Video-Assisted

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (8)

Cited by (10)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:20:13.663096+00:00
License: CC0 · commercial use OK